Mont. health groups recognize National Colorectal Cancer Awareness Month | Study outlines 4 barriers to CRC screening, treatment | Study: Long-term PPI use does not raise fracture risk in Alzheimer's patients
March 19, 2018
CONNECT WITH ACG®
ACG SmartBrief is an official publication of the ACG.
St. Vincent Healthcare and St. Vincent Frontier Cancer Center in Montana are using blue ribbons at its facilities to recognize National Colorectal Cancer Awareness Month in March and raise awareness about the need for screenings. Patient Dan Holm is cancer-free now after being treated for colorectal cancer over a year, and he has become an advocate for early screening.
Four barriers to improving colorectal cancer screening and treatment include limited resources, whether patients understand CRC symptoms and physicians correctly diagnose them, beliefs about health and illness such as self-care and patients' reaction to illness, according to a study in the journal Diseases of the Colon & Rectum. "A comprehensive approach that incorporates all four gaps in screening for colorectal cancer identified by this study will decrease barriers to screening and save lives," Dr. Timothy Geiger wrote in an accompanying editorial.
Long-term use of proton pump inhibitors was not linked to a higher risk of hip fracture in Alzheimer's disease patients, a study in Alimentary Pharmacology & Therapeutics showed. Researchers did find a link between higher hip fracture risk and current PPI use lasting less than a year.
A study published in the journal Inflammatory Bowel Diseases found mice with a Crohn's-like disease that were fed the artificial sweetener Splenda had an overgrowth of E. coli in their intestines, while healthy mice did not. Case Western Reserve University researcher Alex Rodriguez-Palacios said the sweetener may cause inflammation or Crohn's disease flare-ups by changing gut wall immune cell reactivity and gut bacteria.
CMS Administrator Seema Verma announced Friday that the agency will now cover diagnostic laboratory tests that use next-generation DNA sequencing to guide treatment for Medicare patients with stage III or IV cancers or those whose disease is recurrent, metastatic, relapsed or refractory. The decision follows the agency's review of Foundation Medicine's FoundationOne CDx test, which identifies mutations in 324 genes and two genomic signatures in any solid tumor, and the CMS said it will cover similar tests once approved.
Michigan said it will settle a class-action suit regarding a policy that restricts hepatitis C treatments for those in the Medicaid program. New lifesaving antivirals are only offered to patients with hepatitis C who have severe liver damage, according to the lawsuit.
Diagnostic errors topped the ECRI Institute's "Top 10 Patient Safety Concerns for Healthcare Organizations" list. The second biggest concern was opioid safety, followed by care coordination, workarounds and incorporating health IT into patient safety programs.
Roughly 65% of health care organizations said they either did not have a security policy in place to protect medical devices from cyberattacks or were unsure of whether they had such a policy, according to a Merlin International survey. Fifty-two percent of respondents said there was a lack of sufficient awareness among employees regarding secure practices, and 51% said they have an incidence response plan in place.
A poll of 800 US patients found almost 62.8% reported not knowing who has access to their medical data or where it is stored, and more than 90% indicated they don't know if their data is being sold for a profit by the software their doctor's office uses, according to a survey released by Australia-based health technology firm ScalaMed. Almost 80% of respondents reported that they should be the owners of their health data, and nearly half indicated feeling "sidelined" when it comes to managing their medical records.
ACG's SCOPY: Service Award for Colorectal Cancer Outreach, Prevention & Year-Round Excellence annually recognizes the achievements of ACG members in their community engagement, education and awareness efforts for colorectal cancer (CRC) prevention. ACG members are invited to submit examples of projects and programs that demonstrate outstanding creativity and commitment to spreading the potentially lifesaving message of the importance of CRC screening and prevention. The deadline for submissions to the 2018 SCOPY Awards is May 31. Learn more and submit your application.
Maximize your time out of the office by attending ACG's IBD School and Eastern Regional Postgraduate Course, April 13-15, in Boston. Listen to first-rate faculty and participate in hands-on workshop sessions. Learn more and register.